1. Home
  2. BOLD vs INTG Comparison

BOLD vs INTG Comparison

Compare BOLD & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • INTG
  • Stock Information
  • Founded
  • BOLD 2018
  • INTG 1965
  • Country
  • BOLD United States
  • INTG United States
  • Employees
  • BOLD N/A
  • INTG N/A
  • Industry
  • BOLD
  • INTG Building operators
  • Sector
  • BOLD
  • INTG Real Estate
  • Exchange
  • BOLD Nasdaq
  • INTG Nasdaq
  • Market Cap
  • BOLD 33.4M
  • INTG 38.9M
  • IPO Year
  • BOLD 2024
  • INTG N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • INTG $36.97
  • Analyst Decision
  • BOLD Buy
  • INTG
  • Analyst Count
  • BOLD 4
  • INTG 0
  • Target Price
  • BOLD $4.00
  • INTG N/A
  • AVG Volume (30 Days)
  • BOLD 85.6K
  • INTG 13.3K
  • Earning Date
  • BOLD 11-05-2025
  • INTG 11-12-2025
  • Dividend Yield
  • BOLD N/A
  • INTG N/A
  • EPS Growth
  • BOLD N/A
  • INTG N/A
  • EPS
  • BOLD N/A
  • INTG N/A
  • Revenue
  • BOLD N/A
  • INTG $65,385,000.00
  • Revenue This Year
  • BOLD N/A
  • INTG N/A
  • Revenue Next Year
  • BOLD N/A
  • INTG N/A
  • P/E Ratio
  • BOLD N/A
  • INTG N/A
  • Revenue Growth
  • BOLD N/A
  • INTG 9.82
  • 52 Week Low
  • BOLD $1.00
  • INTG $9.57
  • 52 Week High
  • BOLD $3.54
  • INTG $42.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 39.64
  • INTG 45.19
  • Support Level
  • BOLD $1.17
  • INTG $30.44
  • Resistance Level
  • BOLD $1.18
  • INTG $37.28
  • Average True Range (ATR)
  • BOLD 0.07
  • INTG 2.37
  • MACD
  • BOLD -0.01
  • INTG -1.05
  • Stochastic Oscillator
  • BOLD 51.79
  • INTG 7.19

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: